In accordance with the recent report by, Acute Market Reports, Inc., the global market for interventional cardiology and peripheral vascular devices was valued at US$ 14.53 billion in 2016 and increased to CAGR by 8.8%.
Market Insights
Interventional cardiology and peripheral vascular treatment is a preferred alternative to traditional open surgery for cardiovascular disease. Interventional approaches are gaining acceptance in the medical fraternity for the treatment of cardiac disorders and peripheral vascular diseases in order to be safe and effective in terms of treatment outcomes. The market for interventional cardiology and peripheral vascular devices is expected to see steady growth due to increased personal satisfaction among patients with coronary heart disease and peripheral vascular disorders. The future interventional approach will continue to expand as new technologies take over open surgery.
Browse Full Report Originally Published by Acute Market Reports at https://www.acutemarketreports.com/report/interventional-cardiology-peripheral-vascular-devices-market
The global interventional cardiology and peripheral vascular devices market growth is fuelled by increasing cardiovascular ailments and subsequent high rate of death across the world since heart disease caused 633,000 death of Americans in the year 2015, as per data reported by the National Center for Health Statistics. Peripheral arterial disease affect more than 10 million patients, causing further discomfort and serious complications. Sedentary lifestyle with fat-enriched diet habit, increasing tobacco and alcohol consumption, and stress act as triggering factors for cardiovascular diseases. Apart from these, other two major risk factors of cardiovascular diseases are diabetes and obesity which are also on rise, and would successively boost market growth. Adoption of evolving technology in healthcare facilities, increasing number of cardiac catheterization laboratories and increasing fund for ongoing cardiovascular research have positive impact on the market growth.
Based on the type of interventional cardiology and peripheral vascular devices, the market was dominated by angioplasty stents and angioplasty catheters in the year 2016. Increasing proclivity towards minimally invasive surgical procedure, deployment of angioplasty stents and catheters in cardiac procedures are accelerating. This acts as primary driving force for the lucrative market growth due to lower complication and faster recovery.
On the basis of regional segmentation, North America leads the global interventional cardiology and peripheral vascular devices market owing to advanced healthcare infrastructure, increasing healthcare expenditure in order to develop innovative treatment and growing health awareness in people. Rising prevalence of cardiovascular disorders owing to constantly changing lifestyle and increasing geriatric population primarily drive the interventional cardiology and peripheral vascular devices market. Gradually rising number of percutaneous coronary intervention (PCI) centers in the United States also plays as key driver of interventional cardiology and peripheral vascular devices market. The interventional cardiology and peripheral vascular devices market in Asia Pacific region is expected to witness substantial growth due to developing economies and rising initiatives for betterment of health and rising health consciousness.
Market Competition Assessment:
The major industry players of interventional cardiology and peripheral vascular devices market having interventional cardiology and peripheral vascular devices market includes Cook Medical, Inc., Boston Scientific Corporation, Cardinal Health, Inc., St. Jude Medical, Abbott Laboratories, C. R. Bard, Inc., Medtronic plc., Edwards Lifesciences Corporation, Terumo Corporation, B. Braun Melsungen AG, Baxter International Inc., 3M Company, and other notable players.
Key Market Movements:
Table of Content
Chapter
1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter
2. Executive Summary
2.1. Global Interventional Cardiology & Peripheral Vascular Devices Market
Portraiture
2.1.1. Global Interventional Cardiology & Peripheral Vascular Devices
Market, by Product Type, 2016 (US$ Mn)
2.1.2. Global Interventional Cardiology & Peripheral Vascular Devices
Market, by Geography, 2016 vs. 2025 (Value %)
Chapter
3. Interventional Cardiology & Peripheral Vascular Devices Market: Market
Dynamics and Future Outlook
3.1. Market Overview
3.2. Interventional Cardiology & Peripheral Vascular Devices: Future Trends
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Porter’s Five Forces Analysis
3.7. Attractive Investment Proposition, by Geography, 2016
3.8. Major Agreements, Partnerships and Collaborations
3.9. Competitive Landscape
3.9.1. Competitive Landscape, by Key Players, 2016
Chapter
4. Global Interventional Cardiology & Peripheral Vascular Devices Market,
by Product Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Interventional Cardiology
& Peripheral Vascular Devices Market, by Product Type, 2016
4.2. Angioplasty Stents
4.3. Angioplasty Balloon Catheter
4.4. Guidewires
4.5. Vascular Closure Devices
4.6. Peripheral Embolic Protection Devices
4.7. Atherectomy Devices
4.8. Endovascular Stent Grafts
4.9. Vascular Grafts
4.10. Thrombectomy Devices
4.11. Inferior Vena Cava Filter
4.12. Others
Chapter 5. Global Interventional Cardiology & Peripheral Vascular Devices Market, by Geography, 2015 – 2025 (US$ Mn)
……………
About Us
Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
(US/CANADA) Ph.: +1-855-455-8662
E-mail: sales@acutemarketreports.com
Healthcare Sector Poised for Transformation The healthcare industry stands to benefit tremendously from NeuroFlex. Experts…
The science of skin ageing has entered a transformative phase, thanks to advancements in epigenetics-the…
Human metapneumovirus (HMPV) is a respiratory virus first identified in 2001 by researchers in the…
A major breakthrough in telehealth services is set to significantly expand healthcare access in remote…
Digital twin technology, a formidable advancement in simulation and modeling, offers a real-time digital counterpart…
In a groundbreaking study, scientists have discovered that deep-sea metal nodules are capable of producing…